Pharmapex’s Novel Mastitis Treatment Offers Hope to World Farmers
Efficient feed-based mastitis treatment boosts livestock health with unique microencapsulated technology.
San Diego, CA (PRWEB) February 06, 2014
Mastitis can be detrimental to essential milk production and quality in lactating livestock. In low socioeconomic regions of the world, poor milk quality or low production can negatively influence animal health and the livelihood of the farmers who raise them. Traditional treatments for mastitis has involved injections, ingestion of liquid preparations and daily handling of livestock but a new feed additive made from FDA approved ingredients makes prevention and treatment of mastitis both easier and more cost effective.
Pharmapex®, manufacturer and international distributor of quality animal health products announces the addition of Mastcure™ to its MegaFeed™ line of animal feed additives. Mastcure has proven effective in the field and is currently available for sale and distribution in Latin America, Asia-Pacific, the Middle East and North Africa. The MegaFeed line of products is manufactured by Pharmapex's Animal Health Department, which offers high-quality specialty products, including medicated feed, injectable medicine, and vaccines, for the animal health industry around the world. Products are specially formulated and customized to prevent and manage feed-related illnesses and complications for poultry, dairy and beef cattle, horses, sheep, swine and fish. All MegaFeed products are fully researched, certified, and accredited by laboratories in the United States including Romer Labs and Trilogy Analytical Laboratories. Ingredients are approved by U.S. Food and Drug Administration (FDA) and the American Association of Feed Control Officials (AAFCO).
Mastcure is a microencapsulated form of enhanced trisodium citrate encased in a specially formulated protective matrix that when added to animal feed, prevents and treats livestock mastitis. Active ingredients pass through the animal’s rumen and release active ingredients as it enters the small intestine. Release is gradual, distal, and catalyzed by the natural enzymes produced by the animal.
For more information, including complementary technical data, please contact Pharmapex's Animal Health Department. Email to: animalhealth(at)pharmapexusa(dot)com.
For the original version on PRWeb visit: http://www.prweb.com/releases/2014/02/prweb11556048.htm